BridgeMD
New treatment option for Solitary Pulmonary Nodules
Official title Plasma Metabolomics as a Tool to Distinguish PET-positive Malignant From PET-positive Benign Nodules
ClinicalTrials.gov ID: NCT07087080
What this study is testing
- What it's testing
- Positron emission tomography-computed tomography (PET-CT) is an important technique in lung cancer staging, where almost no lung lesion goes undetected. However, PET-CT often fails to discriminate between malignant and non-malignant PET-positive solitary pulmonary nodules (SPNs) with a specificity of only 23%.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults
You may be able to join if
- patients who undergo a PET-CT scan at ZOL for a lung nodule, who are willing to provide written informed consent
You likely can't join if
- no fasting starting 6h prior to blood sampling;
- medication intake on the morning of blood sampling;
- fasting blood glucose concentration is higher than 200 mg/dL in the morning of blood sampling;
- history of cancer during the past five years;
- treatment for cancer during the past five years.
The study team makes the final eligibility decision.
Where it's taking place
- Genk, Limburg, Belgium
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Genk, Limburg, Belgium. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.